- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03927638
Differences in Sitting Versus Standing on Metabolic and Cardiovascular Measurements
January 29, 2025 updated by: Peter A. Hosick, Montclair State University
This investigations examined the effect that posture has on metabolic and cardiovascular measurements.
Further, it will explore the potential for body weight status or physical activity to influence these relationships.
All subjects will complete a seated condition and a standing condition in a counterbalanced manner.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Detailed Description
The purpose of the present study was to evaluate both metabolic and cardiovascular responses to acute bouts of computer work while sitting and standing.
Cardiovascular measurements were made using continuous non-invasive blood pressure monitoring and metabolic measurements were made using indirect calorimetry.
Subjects will be grouped and analyzed based upon the weight status of the subject.
All subjects will complete a seated condition and a standing condition in a counterbalanced manner.
Investigators hypothesize that metabolic and cardiovascular responses will be elevated in the standing condition compared to sitting.
Study Type
Observational
Enrollment (Estimated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Jersey
-
Montclair, New Jersey, United States, 07043
- Montclair State University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Healthy subjects between the ages of 18 and 50 years.
Description
Inclusion Criteria:
- healthy adult
Exclusion Criteria:
- Have a history of cancer, cardiac issues, hypertension, pulmonary disease, stroke, neurological or muscular dystrophy, uncontrolled diabetes, or any life threatening chronic conditions.
- Are currently being treated for infectious mononucleosis, hepatitis, pneumonia, or other infectious diseases.
- Are unable or unwilling to stand in one position continuously for 15-20 minutes at a time.
- Use nicotine products, or non-contraceptive hormonal therapy (birth control is okay).
- Are pregnant or trying to become pregnant.
- Are not between 18 and 50 years of age.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Normal Weight
Group is determined based upon subjects weight status.
Subjects will preform computer work in the seated and standing position in a counterbalanced manner while metabolic and cardiovascular measurements are made.
|
Subjects will be asked to both sit and stand during a single trial.
|
|
Overweight/Obese
Group is determined based upon subjects weight status.
Subjects will preform computer work in the seated and standing position in a counterbalanced manner while metabolic and cardiovascular measurements are made.
|
Subjects will be asked to both sit and stand during a single trial.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart Rate
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
|
Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to measure heart rate based upon beat-by-beat finger pressure.
|
Approximately 15 minutes in each condition (sitting and standing)
|
|
Systolic Blood Pressure (SBP)
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
|
Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to measure SBP based upon beat-by-beat finger pressure.
|
Approximately 15 minutes in each condition (sitting and standing)
|
|
Diastolic Blood Pressure (DBP)
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
|
Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to measure DBP based upon beat-by-beat finger pressure.
|
Approximately 15 minutes in each condition (sitting and standing)
|
|
Oxygen Consumption
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
|
Oxygen consumption will be measured using indirect calorimetry.
|
Approximately 15 minutes in each condition (sitting and standing)
|
|
Carbon Dioxide Production
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
|
Carbon Dioxide will be measured using indirect calorimetry.
|
Approximately 15 minutes in each condition (sitting and standing)
|
|
Ventilation
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
|
Ventilation will be measured using indirect calorimetry.
|
Approximately 15 minutes in each condition (sitting and standing)
|
|
Respiratory Exchange Ration (RER)
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
|
RER will be calculated using oxygen and carbon dioxide value measure from indirect calorimetry.
|
Approximately 15 minutes in each condition (sitting and standing)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Height
Time Frame: 1 minute
|
Standard stadiometer will be used to measure height in meters.
|
1 minute
|
|
Weight
Time Frame: 1 minute
|
Standard scale will be used to measure weight in kilograms.
|
1 minute
|
|
Body Mass Index (BMI)
Time Frame: 1 minute
|
Height in meters and weight in kilograms will be used to calculate BMI using the formula BMI = kg/m^2.
|
1 minute
|
|
Body Composition
Time Frame: Approximately 15 minutes
|
Body composition will be measured using air displacement plethysmography.
|
Approximately 15 minutes
|
|
Total Peripheral Resistance (TPR)
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
|
Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be uses to estimate TPR based upon beat-by-beat finger pressure.
|
Approximately 15 minutes in each condition (sitting and standing)
|
|
Stroke Volume
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
|
Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to estimate TPR based upon beat-by-beat finger pressure.
|
Approximately 15 minutes in each condition (sitting and standing)
|
|
Cardiac Output (Q)
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
|
Using human non-invasive blood pressure continuous monitoring placed on the middle finger of the non-dominant hand will be used to estimate Q based upon beat-by-beat finger pressure.
|
Approximately 15 minutes in each condition (sitting and standing)
|
|
Muscle Oxygen Saturation
Time Frame: Approximately 15 minutes in each condition (sitting and standing)
|
Using Near-inferred spectroscopy muscle oxygen consumption will be monitored.
|
Approximately 15 minutes in each condition (sitting and standing)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 11, 2018
Primary Completion (Estimated)
May 15, 2028
Study Completion (Estimated)
May 15, 2028
Study Registration Dates
First Submitted
April 22, 2019
First Submitted That Met QC Criteria
April 24, 2019
First Posted (Actual)
April 25, 2019
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
January 29, 2025
Last Verified
October 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-18-861
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
National Taiwan University HospitalCompleted
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
Clinical Trials on sit/stand
-
Hamilton Health Sciences CorporationOntario Ministry of Health and Long Term CareUnknownCerebrovascular AccidentCanada
-
Riphah International UniversityCompletedCerebral PalsyPakistan
-
Lisa GriffinRecruitingHealthy Aging | Diabetic Peripheral Neuropathy | Diabetic Peripheral Neuropathy Type 2 | Diabetic Peripheral Neuropathy Type 2 - UncontrolledUnited States
-
University of MinnesotaMayo ClinicCompletedSedentaryUnited States
-
University of ZurichCompletedHealthy IndividualsSwitzerland
-
Cliniques universitaires Saint-Luc- Université...Completed
-
University Rehabilitation Institute, Republic of...WithdrawnLower Limb AmputationSlovenia
-
University Hospital, RouenTerminated
-
Arizona State UniversityUniversity of MinnesotaCompleted